Cytosorbents Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-02-08
Share capital
5,000.00 PLN
Registered address
Aleja Armii Ludowej 26, 00-609 Warszawa, Poland
Electronic delivery address
AE:PL-68631-43166-VVHHJ-14

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk. Sprawozdanie finansowe zostało sporządzone przy założeniu kontynuacji działalności gospodarczej w dającej się przewidzieć przyszłości. Pomimo wystąpienia okoliczności wynikających z art. 233 KSH, które wskazywałyby na zagrożenie kontynuacji działalności Spółka będzie kontynuować działalność gospodarczą w nie zmniejszonym zakresie, bez postawienia jej w stan likwidacji lub upadłości. Udziałowcy Spółki podejmą w tej kwestii stosowną uchwałę.

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 10 days late).

  • 2025filed
  • 202401/04/2025
  • 202321/03/2024
  • 202205/04/2023
  • 202125/07/2022
  • 202022/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods503 / 1,141
Top 44%
Division · Wholesale trade6,600 / 19,990
Top 33%
City · Warszawa9,938 / 56,980
Top 17%
Voivodeship · Mazowieckie14,123 / 77,137
Top 18%
Country · Poland55,009 / 297,935
Top 18%

Results vs industry

Revenue
This companyUSD 2.36mMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD -569.12kMedianUSD 37.89kAverageUSD 879.28k
Operating costs
This companyUSD 2.82mMedianUSD 929.75kAverageUSD 21.06m
Assets
This companyUSD 1.21mMedianUSD 609.81kAverageUSD 11.84m

Public procurement

75 tenders recorded as contractor: 18 national ($1,102,462) and 57 EU ($6,739,316).

SubjectAmount
Purchase and delivery of an ECMO procedure set, a whole-blood adsorber, steerable vascular sheaths and aortic valves, together with the lease of accessories.
$506.4K
Supply of single-use medical supplies, with the option of submitting bids for individual lots – as specified in the assortment and pricing form constituting Annex 3 to SWZ (lots 1-34).
–
Supply of transseptal puncture catheters and adsorption columns for 24 months – reference number: Z/71/PN/26
$216K

Authorized Representatives

Ewa Ryżanowska – Management Board Member
Moritz Fischer – President of the Management Board
Marcin Sobieszek – Management Board Member

Manner of representation

Each member of the management board represents the company independently.

Ownership

OwnerSharesShare valueStake
Cytosorbents Europe Gmbh
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-03-01.

  • Alior Bank
    13 2490 0005 0000 4600 6640 4646
  • mBank
    24 1140 1078 0000 7179 7600 1002
  • mBank
    51 1140 1078 0000 7179 7600 1001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Balmed Polandsp. z o.o.
Medikon Polskasp. z o.o.
American Way Polska Miłkowskisp. k.
Brandexsp. z o.o.
PUBE Globalsp. z o.o.
Tricopat Globalsp. z o.o.
Novicaresp. z o.o.
Dental Solutionssp. z o.o.
Beauty Care Solutionsp. z o.o.
Aimedicalsp. z o.o.

Change history

DateEvent
2025-02-19Address change
2025-02-19PKD change
2019-02-08Entered in the register

FAQ

Last updated: 2026-10-07